Cargando…
A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache
Twenty-three patients, aged 18‐66 years and suffering from migraine with or without aura, were randomly selected to receive either vigabatrin or matched placebo tablets first for 12 weeks in a double-blind crossover study. Alternative treatment was given after a 4-week washout period. The dose of me...
Autores principales: | Ghose, Karabi, Niven, Brian E., Berry, Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag Italia
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613231/ http://dx.doi.org/10.1007/s101940200022 |
Ejemplares similares
-
A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
por: Dzator, Jemima S. A., et al.
Publicado: (2022) -
Co-morbidity of migraine and epilepsy: a review of clinical features
por: Flanagan, Danny, et al.
Publicado: (2000) -
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials
por: Jenssen, Astrid Bjørke, et al.
Publicado: (2019) -
Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial
por: Gross, Elena, et al.
Publicado: (2019) -
Evaluation of a Polyherbal Formulation on the Management of Migraine Headaches due to Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Anushiravani, Majid, et al.
Publicado: (2022)